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Abstract SNAP-25 is located on the plasma membrane and 
essential for exocytosis of neurotransmitters. It was suggested 
that SNAP-25 and syntaxin 1 via the interaction with VAMP-2 
located on synaptic vesicles mediate the docking of the vesicles 
with the plasma membrane. In the present study, by means of 
biochemical and morphological analyses, we showed that SNAP- 
25 is present on chromaffin granules as well as on the plasma 
membrane. Reconstitution and immunoprecipitation analyses 
revealed that SNAP-25 on chromaffin granules has essentially 
the same properties as does SNAP-25 on the plasma membrane. 
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I. Introduction 
Recent progress has revealed that a common principle 
works for the membrane fusion events in neurotransmitter 
release and intracellular vesicle-mediated protein transport. 
Rothman and colleagues identified NSF and SNAPs as fac- 
tors that mediate intra-Golgi protein transport (for reviews, 
see Refs. [1,2]). NSF  is an ATPase and contains two homo- 
logous nucleotide-binding regions [3,4], and SNAPs mediate 
the association of NSF with membranes [5,6]. S611ner et al. [7] 
identified VAMP-2 [8,9], syntaxin 1 [10-12], and SNAP-25 
[13] as SNAP receptors (SNAREs). NSF, SNAPs and 
SNAREs are associated to form a 20S complex in membranes, 
and this complex is disassembled by Mg2+-ATP, whereby 
NSF is released from the membranes [7,14,15]. 
Based on the localization of SNAREs [8-10,13,16], VAMP- 
2 was classified as a v-SNARE, and syntaxin 1 and SNAP-25 
as t -SNAREs [7]. SNARE hypothesis predicts that the dock- 
ing of vesicles with target membranes i mediated by the spe- 
cific interaction between t- and v-SNAREs [7]. Although the 
involvement of NSF-SNAPs-SNAREs in various fusion 
events including exocytosis in chromaffin cells [17-20], recent 
studies revealed that t -SNAREs are localized not only on the 
plasma membrane but also on synaptic vesicles [21-23]. These 
results raised the question of whether or not syntaxin 1 and 
SNAP-25 act as t-SNAREs. However, syntaxin 1 and SNAP- 
25 may be incorporated into the vesicles due to incomplete 
v-SNARE-t-SNARE-dissociat ion after fusion [22], because re- 
cycling of  synaptic vesicle proteins from the plasma mere- 
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brane occurs rapidly and this event is important for the bio- 
genesis of synaptic vesicles [24-26]. 
Chromaffin granules are organelles involved in the exocy- 
tosis of catecholamines, but not in the recycling process. We 
recently showed that syntaxin 1 exists on chromaffin granules 
as well as on the plasma membrane [27]. In the present study, 
we showed that a significant amount of SNAP-25 is present 
on chromattin granules as well as on the plasma membrane. 
2. Materials and methods 
2.1. Materials 
Monoclonal antibodies against the following proteins were de- 
scribed previously: brain syntaxin 1B (MAb 6H1) [11], SNAP-25 
(MAb BR05) [28,29], and NSF (MAb 2C83 [4]. Antibodies against 
VAMP-2 (residues 2-19) and SNAP-25 (residues 195-206) were kindly 
donated by Dr. M. Takahashi (Mitsubishi Kasei Institute of Life 
Sciences). Polyclonal antibodies against he whole SNAP-25 protein 
and SNAP were kindly donated by Dr. R. Jahn (Yale University) and 
Dr. J.E. Rothman (Memorial Sloan-Kettering Cancer Center), respec- 
tively. Unless otherwise stated, MAb 6H1, MAb BR05 and anti- 
VAMP-2 peptide antibody were used for immunoblotting. Escherichia 
coli-expressed NSF and o~-SNAP were purified as described by Tagaya 
et al. [4] and Whiteheart et al. [30], respectively. 
2.2. Subeellular J~'actionation a d velocity sedimentation 
Chromaffin granules from bovine adrenal medullae were isolated by 
centrifugation on step gradients of sucrose or Percoll as described 
previously [27]. The membranes were prepared by centrifugation at 
200 000 × g~v for 40 min after hypo-osmotic treatment. Sucrose qui- 
librium density gradient centrifugation was conducted as described 
previously [27]. 
2.3. Immunoelectron microscopy 
Purified chromaffin granules were attached to collodion-carbon- 
coated nickel grids (150 mesh), incubated with buffer A (PBS contain- 
ing 0.25 M sucrose and 0.5% BSA) for 10 min, and then treated with 
the first antibodies (10 gg/ml of lgG) in buffer A for 2 h. After 
washing, the granules were incubated with gold particles (10 nm) 
conjugated to goat IgG against mouse or rabbit IgG (British BioCell 
International, Cardiff, UK) in buffer A for 30 min, and then washed 
several times with 0.1 M cacodylate buffer (pH 7.4) containing 0.25 M 
sucrose. The granules were then fixed in 2% glutaraldehyde in the 
same buffer, and washed with distilled water. Absorption staining of 
the chromaffin granules on the grids was carried out with 0.3% uranyl 
acetate and 3% polyvinyl alcohol as described previously [31]. 
2.4. Immunoprecipitation 
Chromaffin granule membranes were solubilized with 1% Triton X- 
100 in EDTA-ATP buffer (25 mM HEPES (pH 7.23, 4 mM EDTA, 
0.5 mM ATP, 0.1 M KC1, 0.5 mM dithiothreitol). After centrifugation 
at 200 000 × g~v for 30 rnin, the supernatant was incubated with ap- 
propriate antibodies at 0°C for 1 h. To this solution was added 30 gl 
of protein A/G plus-agarose (Santa Cruz Biotechnology). After gentle 
shaking overnight, he resin was washed, and the bound proteins were 
eluted with SDS sample buffer with boiling. After SDS-PAGE [32], 
the proteins were detected by immunoblotting with appropriate anti- 
bodies. 
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3. Results 
3.1. Evidence for the presence of  SNAP-25 on chromaJfin 
granules 
SNAP-25 is expressed in chromaffin cells, although the ex- 
pression level is about 20-fold lower than that in brain [33]. 
When highly purified chromaffin granules were analyzed by 
immunoblotting, immunoreactivity for SNAP-25 as well as 
VAMP-2 and syntaxin 1 was detected (Fig. 1). No significant 
contamination by Na+,K+-ATPase, a marker protein of the 
plasma membrane, was detected on isolated chromaffin gran- 
ules (Fig. 1), excluding the possibility that the SNAP-25 de- 
tected on the granule membranes was derived from contam- 
inating plasma membranes. As shown in Fig. 2, sucrose 
equilibrium density centrifugation revealed that the amount 
of SNAP-25 in the precipitate, on which chromaffin granules 
are located, was comparable to those for fractions 4 and 5, 
which contained the plasma membrane and microvesicles, 
when detected with MAb BR05. This suggests that granule- 
associated SNAP-25 represents a significant portion of the 
total SNAP-25 pool in chromaffin cells. 
We previously reported that SNAP-25 was not detected on 
chromaffin granules when analyzed with an antibody against 
the carboxyl-terminal residues (195-206) of brain SNAP-25 
[27]. This was probably due to the inefficient immunoblotting. 
When samples contain large amounts of membranes, the elec- 
trophoresis pattern is disturbed and, in addition, the efficiency 
of immunostaining is considerably lower than that for samples 
without membranes. In Triton X-100 extracts of chromaffin 
granules, immunoreactivity was detected with an anti-SNAP- 
25 peptide antibody, MAb BR05, and an antibody against he 
whole SNAP-25 protein (Fig. 2B). On the other hand, as 
observed previously [27], no immunoreactivity was detected 
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Fig. I. SNAP-25 is co-purified with chromaffin granules. A postnu- 
clear supernatant (PNS), chroma~n granules isolated by sucrose 
gradient centrifugation (sucrose C.G.) or Percol! gradient centrifuga- 
tion (Percoll C.G.), total membranes (TOTAL MEM.), and chro- 
martin granule membranes (C.G.M.) were subjected to SDS-PAGE, 
and then immunoblotted. The sarfie amount of proteins was ana- 
lyzed in each series of SDS-PAGE. (A) Purity of chromaffin gran- 
ules. Immunoblotting was carried out with antibodies against a 
chromaffin granule marker protein, chromogranin A (CgA), a mito- 
chondrial marker protein, adrenodoxin (Ad), and a plasma mem- 
brane marker enzyme, Na +, K+-ATPase (NaK). (B) Presence of 
SNAP-25 on chromaffin granules. Immunoblotting was carried out 
with antibodies against SNAREs. MAb BR05 was used for immu- 
nostaining for SNAP-25. An immunoreactive band corresponding to 
a molecular weight lower than that of SNAP-25 was occasionally 
observed. This band may represent a proteolytic fragment of 
SNAP-25. 
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Fig. 2. Subcellular f actionation of adrenal medulla. (A) A postnu- 
clear supernatant was subjected to sucrose quilibrium centrifuga- 
tion, and then membranes were recovered by centrifugation after 
hypoosmotic treatment. After SDS-PAGE, proteins were immuno- 
blotted with the following antibodies: MAb (6H1 (SYNTAXIN 
1B), anti-SNAP-25 peptide antibody (SNAP-25 (PEP)), MAb BR05 
(SNAP-25 (BR05)), anti-VAMP-2 antibody (VAMP), and anti- 
Na*,K+-ATPase antibody (NaK). (B) Membranes were solubilized 
with Triton X-100, and then the solubilized proteins were subjected 
to SDS-PAGE, and immunoblotted with MAb BR05 (BR05), anti- 
SNAP-25 peptide (PEP), and anti-SNAP-25 protein (WHOLE). 
with the anti-SNAP-25 peptide antibody when the chromaffin 
granule fraction was subjected to electrophoresis without Tri- 
ton X-100 treatment (Fig. 2A). 
To confirm the association of SNAP-25 with chromaffin 
granules, we carried out immunogold labeling of isolated 
chromaffin granules. In chromaffin cells, there are two types 
of granules, one comprising less dense and the other dense- 
core vesicles. It is known that the former and latter contain 
adrenalin and nonadrenalin, respectively [34]. Electron 
microscopy demonstrated that immunoreactivities for 
VAMP-2 (Fig. 3A) and SNAP-25 (Fig. 3B and C) were ob- 
served on both types of granules, although the reactivity for 
SNAP-25 was less intense. No significant labeling was ob- 
served on either granule when a control antibody was used 
(Fig. 3D). As judged from the density of the organelles, it is 
obvious that they are not endsomes. 
3.2. SNAP-25 on chromaffin granules acts as a SNAP receptor 
Syntaxin 1 and SNAP-25 on the plasma membrane 
[15,35,36] and syntaxin 1 on chromaffin granules [27] can 
form a complex with VAMP-2. We examined whether or 
not SNAP-25 on chromaffin granules also forms a complex 
with VAMP-2 and syntaxin 1. As shown in Fig. 4A, SNAP-25 
and syntaxin 1were co-immunoprecipitated withanti-VAMP- 
2, whereas none of the three proteins were precipitated when a 
control antibody was used. This suggests that SNAP-25 on 
the granules can form a complex with syntaxin 1 and VAMP- 
2. Consistent with this idea, both SNAP-25 and syntaxin 1 
were co-immunoprecipitated with anti-syntaxin 1 or anti- 
SNAP-25 (Fig. 4B). However, only a small amount of 
VAMP-2 was co-immunoprecipitated with both antibodies. 
This contradiction can be reconciled by the idea that the 
amount of VAMP-2 in chromaffin granules is much higher 
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than those of syntaxin 1and SNAP-25, and major portions of 
syntaxin 1 and SNAP-25, and a minor portion of VAMP-2 
form a complex. Perhaps, the efficiency of immunostaining 
with anti-VAMP-2 was much lower than those with anti- 
SNAP-25 and anti-syntaxin. 
c~-SNAP binds to plasma membrane-associated SNAP-25, 
although it more tightly binds to the complex of syntaxin, 
SNAP-25 and VAMP-2 [37,38], To determine whether or 
not cx-SNAP binds to granule-associated SNAP-25, a Triton 
X-100 extract of chromaffin granule membranes was incu- 
bated with E. coli-expressed (x-SNAP, and then immunopre- 
cipitated with an antibody against SNAP-25 or SNAP. As 
shown in Fig. 5A and B, a-SNAP was co-immunoprecipitated 
with the anti-SNAP-25, and conversely SNAP-25 was co-im- 
munoprecipitated with the anti-SNAP, indicating that SNAP- 
25 can act as a SNAP receptor. Since c~-SNAP does not di- 
rectly bind to VAMP-2 [37,38], co-immunoprecipitation of 
SNAP with anti-VAMP-2 (Fig. 5A) is consistent with the 
idea that VAMPo2 can form a complex with syntaxin 1 and 
SNAP-25 on chromaffin granules. The low efficiency of co- 
immunoprecipitation of VAMP-2 with anti-SNAP (Fig. 5B) 
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Fig. 3. lmmunogold labeling for SNAP-25 and VAMP-2. immuno- 
gold labeling was carried out with anti-VAMP-2 (A), anti-SNAP-25 
(MAb BR05) (B and C), and a control mouse IgG (D). Bar, 300 
r im.  
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Fig. 4. Co-immunoprecipitation of SNAREs. (A) A Triton X-100 
extract of chromaffin granule membranes was immunoprecipitated 
with a control antibody (CONTROL) and anti-VAMP-2 (Anti- 
VAMP-2). The precipitates were subjected to SDS-PAGE and im- 
munoblotted with antibodies against SNAREs. (B) Immunoprecipi- 
tation was performed with anti-syntaxin IB (MAb 6HI) (lanes 1 
and 2), anti-SNAP-25 (MAb BR05) (lanes 3 and 4), and anti- 
VAMP-2 (lanes 5 and 6). The precipitates (lanes 1, 3 and 5) and 
supernatants (lanes 2, 4 and 6) were subjected to SDS-PAGE, and 
then immunoblotted with a mixture of antibodies against SNAREs. 
may reflect the fact that the SNAP-25 is a limiting component 
for the formation of the SNARE complex, as described above. 
We next examined whether or not SNAP-25 is a component 
of the 20S fusion complex. For this purpose, a Triton X-100 
extract of chromaffin granules was incubated with E. coli-ex- 
pressed NSF and c~-SNAP, and then the complex was immu- 
noprecipitated with anti-NSF (MAb 2C8). As shown in Fig. 
5C, SNAP-25 was co-immunoprecipitated withMAb 2C8, but 
not with a control antibody. 
4. Discussion 
In a previous tudy, we showed that syntaxin 1is present on 
chromaffin granules as well as on the plasma membrane [27]. 
In the present study, we have demonstrated that SNAP-25 is 
also present on chromaffin granules. The amounts of syntaxin 
1 and SNAP-25 on chromaffin granules are not trivial por- 
tions of the total pool of the two proteins in chromaffin cells. 
Since chromaffin granules are organelles that exclusively par- 
ticipate in exocytosis, the presence of syntaxin 1and SNAP-25 
on the granules unequivocally excludes the possibility that 
these proteins are accidentally incorporated into transport 
vesicles. The present and other results [22,27] raise a question 
regarding the docking model of vesicles with target mem- 
branes, which is based on the different localization of t- and 
v-SNAREs. It was recently suggested that VAMP-2 and syn- 
taxin play roles after the docking of synaptic vesicles at the 
active zone of the plasma membrane [39]. 
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Fig. 5. (A) Co-immunoprecipitation of a-SNAP with SNAREs. A 
Triton X-100 extract of chromaffin granule membranes was incu- 
bated with E. coil-expressed a-SNAP, and then immunoprecipitated 
with a control antibody (lane 1), anti-syntaxin 1 (MAb 6H1) (lane 
2), anti-SNAP-25 (MAb BR05) (lane 3), and anti-VAMP-2 (lane 4). 
The immunoprecipitated proteins were subjected to SDS-PAGE, 
and then immunoblotted with anti-SNAP. (B) Co-immunoprecipita- 
tion of SNAP-25 with (x-SNAP. A Triton X-100 extract of chromaf- 
fin granule membranes was incubated without (lane 1) or with (lane 
2) E. col#expressed m-SNAP. The proteins co-immunoprecipitated 
with anti-SNAP were immunodetected. (C) Co-immunoprecipitation 
of SNAP-25 with NSF. A Triton X-100 extract was incubated with 
NSF and a-SNAP, and then immunoprecipitated with a control 
antibody (lanes 1 and 2) and MAb 2C8 (lanes 3 and 4). The pre- 
cipitates (lane 1 and 3) and supernatants (lane 2 and 4) were immu- 
nodetected. 
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